Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q64089309> ?p ?o ?g. }

Showing items 1 to 100 of ±109 with 100 items per page.

Q64089309 description "article scientifique publié en 2019" @default.
Q64089309 description "artículu científicu espublizáu n'abril de 2019" @default.
Q64089309 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
Q64089309 description "scientific article published on 01 April 2019" @default.
Q64089309 description "wetenschappelijk artikel" @default.
Q64089309 description "наукова стаття, опублікована у квітні 2019" @default.
Q64089309 name "A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol" @default.
Q64089309 name "A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol" @default.
Q64089309 type Item @default.
Q64089309 label "A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol" @default.
Q64089309 label "A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol" @default.
Q64089309 prefLabel "A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol" @default.
Q64089309 prefLabel "A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol" @default.
Q64089309 P1433 Q64089309-48BD0170-5CFC-488F-80F0-C9B9680EBFAA @default.
Q64089309 P1476 Q64089309-468AE2C3-524B-4FF2-9035-398EFD8A2C4C @default.
Q64089309 P2093 Q64089309-07BABAF7-551D-4543-82E4-71DD411898D5 @default.
Q64089309 P2093 Q64089309-092EC26B-A288-4B78-B84F-3EAF77E36CE4 @default.
Q64089309 P2093 Q64089309-50FE0231-8954-47B3-B215-C79F7B8F3630 @default.
Q64089309 P2093 Q64089309-5A5782B1-E213-4E95-9B70-A02A0E3257EA @default.
Q64089309 P2093 Q64089309-7E644378-2F81-49A6-831C-2BC65105E5F3 @default.
Q64089309 P2093 Q64089309-9B718600-BB18-4203-AC3E-3B4781C53836 @default.
Q64089309 P2093 Q64089309-A05D7A9D-35D0-442F-8C85-7D3AF6C394DB @default.
Q64089309 P2093 Q64089309-B11CB14E-4187-4145-86A9-F45FF76F5937 @default.
Q64089309 P2093 Q64089309-B1974054-02E7-46BA-8225-8A9872541E0C @default.
Q64089309 P2093 Q64089309-C9E71FBD-AC8E-4DC2-B100-ACF9A371865A @default.
Q64089309 P2093 Q64089309-E1CCC615-2266-4B7E-A589-197D4EFD9FAA @default.
Q64089309 P275 Q64089309-7a3038d8-0fef-436a-9ceb-f54596a5ab18 @default.
Q64089309 P2860 Q64089309-1164CFA6-1CCF-4614-865D-116A91F8D5FD @default.
Q64089309 P2860 Q64089309-20323442-0191-4FF9-BBB8-8B31E9CFAEAC @default.
Q64089309 P2860 Q64089309-28CF8703-60B0-4F04-B666-F9458C2ADF6C @default.
Q64089309 P2860 Q64089309-2B37BD58-E891-4D79-91AB-45F087D966EB @default.
Q64089309 P2860 Q64089309-337428A8-62DA-4E5F-957B-22E8296D3B2C @default.
Q64089309 P2860 Q64089309-4E14B78A-7B6D-482D-9384-29BE6F8843BC @default.
Q64089309 P2860 Q64089309-53564983-B1F9-4FBB-88B6-8B81C0772004 @default.
Q64089309 P2860 Q64089309-5821BB10-1BA2-4DDF-9BAE-B47001607790 @default.
Q64089309 P2860 Q64089309-60DDE8C6-7DCB-45B5-9795-91DB88C9E41F @default.
Q64089309 P2860 Q64089309-6444CA5B-04F8-4EFF-A0E3-624F1F21C9CF @default.
Q64089309 P2860 Q64089309-6B64CE57-01CE-487A-9475-DDCB89BA48EF @default.
Q64089309 P2860 Q64089309-6F97DE6B-E406-4818-BADD-D0CDCD17D43A @default.
Q64089309 P2860 Q64089309-84F7C499-B236-4AE4-B0F2-36A392175789 @default.
Q64089309 P2860 Q64089309-8892DEA7-398E-4B46-9426-3EA67A385A1F @default.
Q64089309 P2860 Q64089309-C033F856-5B66-4F95-A69E-79EF0D513FA6 @default.
Q64089309 P2860 Q64089309-C3637E26-7D01-4DBF-BD28-D3A2CA1BEF08 @default.
Q64089309 P2860 Q64089309-D5187759-DB21-4B16-AC98-BBB739A27207 @default.
Q64089309 P2860 Q64089309-E59D31A6-6F48-4D2A-A3C3-596452D6477E @default.
Q64089309 P2888 Q64089309-7F652790-930B-4174-AF20-FEB635D2BC53 @default.
Q64089309 P304 Q64089309-5BCB0639-0B9C-4AFA-BA41-7F23679E0091 @default.
Q64089309 P31 Q64089309-522A096F-62C0-48A3-ADAA-758865858FB7 @default.
Q64089309 P356 Q64089309-25A51C8D-0674-4AE6-84F9-D613DF514FB4 @default.
Q64089309 P407 Q64089309-FB9B61D0-AAB4-4EDD-A0C3-895D3D14229B @default.
Q64089309 P433 Q64089309-28C6A842-8AFE-4ED5-B591-54271DAD4E38 @default.
Q64089309 P478 Q64089309-15937257-0360-4F9F-9651-02DEBFB6E0EC @default.
Q64089309 P50 Q64089309-7DED6142-FA79-439C-AF9D-43F1B6E11D61 @default.
Q64089309 P50 Q64089309-7EE3EC3F-3CEF-4E4C-A6A4-9677CC800695 @default.
Q64089309 P577 Q64089309-9D515051-6CF2-4E69-B986-0D6F176FBBD5 @default.
Q64089309 P6179 Q64089309-3ED43565-AC9F-4F2D-86DF-C36ACF2E4F6B @default.
Q64089309 P6216 Q64089309-cc6828b7-1af6-4ed9-884f-5be9c8747159 @default.
Q64089309 P698 Q64089309-D8C244E1-9053-4F42-9A27-55959FA9AFD3 @default.
Q64089309 P921 Q64089309-F08FA470-6184-451E-A250-A67DA78A4B55 @default.
Q64089309 P932 Q64089309-01C13521-D49C-4930-B98F-AE7044832478 @default.
Q64089309 P356 S12885-019-5444-4 @default.
Q64089309 P698 30935375 @default.
Q64089309 P1433 Q326300 @default.
Q64089309 P1476 "A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol" @default.
Q64089309 P2093 "Angelica Mondragon" @default.
Q64089309 P2093 "Anna-Barbara Moscicki" @default.
Q64089309 P2093 "Chiu-Hsieh Hsu" @default.
Q64089309 P2093 "Eileen Dimond" @default.
Q64089309 P2093 "Francisco Garcia" @default.
Q64089309 P2093 "Heide Woo" @default.
Q64089309 P2093 "Hillary DeRose" @default.
Q64089309 P2093 "Susan Vanzzini" @default.
Q64089309 P2093 "Valerie Butler" @default.
Q64089309 P2093 "Vikrant V Sahasrabuddhe" @default.
Q64089309 P2093 "Yi Zeng" @default.
Q64089309 P275 Q20007257 @default.
Q64089309 P2860 Q30408577 @default.
Q64089309 P2860 Q35268615 @default.
Q64089309 P2860 Q35869579 @default.
Q64089309 P2860 Q36584416 @default.
Q64089309 P2860 Q36977720 @default.
Q64089309 P2860 Q37466826 @default.
Q64089309 P2860 Q37710523 @default.
Q64089309 P2860 Q42257816 @default.
Q64089309 P2860 Q45206974 @default.
Q64089309 P2860 Q45375225 @default.
Q64089309 P2860 Q47554977 @default.
Q64089309 P2860 Q47714066 @default.
Q64089309 P2860 Q47951363 @default.
Q64089309 P2860 Q50098691 @default.
Q64089309 P2860 Q51865830 @default.
Q64089309 P2860 Q52650189 @default.
Q64089309 P2860 Q69993406 @default.
Q64089309 P2860 Q80313372 @default.
Q64089309 P2888 s12885-019-5444-4 @default.
Q64089309 P304 "290" @default.
Q64089309 P31 Q13442814 @default.
Q64089309 P356 "10.1186/S12885-019-5444-4" @default.
Q64089309 P407 Q1860 @default.
Q64089309 P433 "1" @default.